GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,349,000 | +45.9% | 98,289 | -10.9% | 0.00% | +50.0% |
| Q4 2020 | $1,610,000 | +4.4% | 110,298 | +1.5% | 0.00% | 0.0% |
| Q3 2020 | $1,542,000 | -13.1% | 108,618 | -10.0% | 0.00% | -33.3% |
| Q2 2020 | $1,775,000 | +359.8% | 120,633 | +28.6% | 0.00% | +200.0% |
| Q1 2020 | $386,000 | -14.8% | 93,771 | -0.5% | 0.00% | 0.0% |
| Q4 2019 | $453,000 | -19.5% | 94,271 | +1.5% | 0.00% | 0.0% |
| Q3 2019 | $563,000 | -9.5% | 92,899 | -3.1% | 0.00% | 0.0% |
| Q2 2019 | $622,000 | -2.5% | 95,849 | +6.4% | 0.00% | 0.0% |
| Q1 2019 | $638,000 | +42.7% | 90,042 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $447,000 | +32.6% | 92,042 | +100.9% | 0.00% | 0.0% |
| Q3 2018 | $337,000 | +7.7% | 45,806 | -6.7% | 0.00% | 0.0% |
| Q2 2018 | $313,000 | +31.5% | 49,086 | +12.1% | 0.00% | – |
| Q1 2018 | $238,000 | +28.6% | 43,777 | -1.2% | 0.00% | – |
| Q4 2017 | $185,000 | -61.0% | 44,327 | -9.9% | 0.00% | -100.0% |
| Q3 2017 | $474,000 | -17.3% | 49,220 | +1.6% | 0.00% | 0.0% |
| Q2 2017 | $573,000 | -7.0% | 48,445 | +0.8% | 0.00% | 0.0% |
| Q1 2017 | $616,000 | +10.0% | 48,037 | +5.1% | 0.00% | 0.0% |
| Q4 2016 | $560,000 | +0.5% | 45,716 | -3.1% | 0.00% | -50.0% |
| Q3 2016 | $557,000 | +38.2% | 47,198 | +1.9% | 0.00% | +100.0% |
| Q2 2016 | $403,000 | +84.9% | 46,298 | +11.7% | 0.00% | 0.0% |
| Q1 2016 | $218,000 | -31.2% | 41,449 | +1.6% | 0.00% | 0.0% |
| Q4 2015 | $317,000 | +7.8% | 40,799 | +9.4% | 0.00% | 0.0% |
| Q3 2015 | $294,000 | -9.5% | 37,309 | +4.0% | 0.00% | 0.0% |
| Q2 2015 | $325,000 | -35.8% | 35,880 | -8.0% | 0.00% | 0.0% |
| Q1 2015 | $506,000 | +15.3% | 39,015 | +20.8% | 0.00% | 0.0% |
| Q4 2014 | $439,000 | +56.2% | 32,290 | +3.2% | 0.00% | 0.0% |
| Q3 2014 | $281,000 | -33.6% | 31,290 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $423,000 | +65.9% | 31,290 | +21.8% | 0.00% | 0.0% |
| Q1 2014 | $255,000 | -29.4% | 25,692 | -5.2% | 0.00% | 0.0% |
| Q4 2013 | $361,000 | +15.0% | 27,112 | +5.0% | 0.00% | 0.0% |
| Q3 2013 | $314,000 | +18.9% | 25,812 | +1.1% | 0.00% | 0.0% |
| Q2 2013 | $264,000 | – | 25,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |